These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19089570)

  • 21. Involvement of the eyebrow fat pad in Graves' orbitopathy.
    Goldberger S; Sarraf D; Bernstein JM; Hurwitz JJ
    Ophthalmic Plast Reconstr Surg; 1994 Jun; 10(2):80-6. PubMed ID: 8086367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
    Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A
    Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extraocular muscle changes in experimental orbital venous stasis: some similarities to Graves' orbitopathy.
    Saber E; McDonnell J; Zimmermann KM; Yugar JE; Feldon SE
    Graefes Arch Clin Exp Ophthalmol; 1996 May; 234(5):331-6. PubMed ID: 8740255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Color Doppler imaging of orbital vasculature before and after orbital decompression in thyroid eye disease.
    Jamshidian-Tehrani M; Nekoozadeh S; Alami E; Ghadimi H; Nabavi A; Ameli K; Sharif Kashani S; Kashkouli MB; Sadeghi-Tari A
    Orbit; 2019 Jun; 38(3):173-179. PubMed ID: 30142011
    [No Abstract]   [Full Text] [Related]  

  • 25. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
    Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
    Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
    Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D
    J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Color Doppler imaging in thyroid eye disease and its correlation to disease activity.
    Jamshidian-Tehrani M; Nabavi A; Kasaee A; Hasanpoor N; Elhami E; Sharif-Kashani S; Masoumi A; Nowroozzadeh MH; Sadeghi-Tari A
    Orbit; 2019 Dec; 38(6):440-445. PubMed ID: 30628510
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in peripapillary blood vessel density in Graves' orbitopathy after orbital decompression surgery as measured by optical coherence tomography angiography.
    Lewis KT; Bullock JR; Drumright RT; Olsen MJ; Penman AD
    Orbit; 2019 Apr; 38(2):87-94. PubMed ID: 29517388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of blood flow in the superior ophthalmic vein using phase contrast magnetic resonance imaging.
    Promelle V; Bouzerar R; Milazzo S; Balédent O
    Exp Eye Res; 2018 Nov; 176():40-45. PubMed ID: 29959927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orbital decompression for disfiguring exophthalmos in thyroid orbitopathy.
    Lyons CJ; Rootman J
    Ophthalmology; 1994 Feb; 101(2):223-30. PubMed ID: 8115142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current insights into animal models of Graves' disease and orbitopathy.
    Wiesweg B; Johnson KT; Eckstein AK; Berchner-Pfannschmidt U
    Horm Metab Res; 2013 Aug; 45(8):549-55. PubMed ID: 23613015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The initial clinical characteristics of Graves' orbitopathy vary with age and sex.
    Kendler DL; Lippa J; Rootman J
    Arch Ophthalmol; 1993 Feb; 111(2):197-201. PubMed ID: 8431156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
    Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orbital computed tomographic characteristics of globe subluxation in thyroid orbitopathy.
    Rubin PA; Watkins LM; Rumelt S; Sutula FC; Dallow RL
    Ophthalmology; 1998 Nov; 105(11):2061-4. PubMed ID: 9818606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orbital decompression for non-Graves' orbitopathy: a consideration of extended indications for decompression.
    Goldberg RA; Hwang MM; Garbutt MV; Shorr N
    Ophthalmic Plast Reconstr Surg; 1995 Dec; 11(4):245-52; discussion 253. PubMed ID: 8746815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [COEXISTENCE OF ORBITAL VARICOSE VEIN AND THYROID ORBITOPATHY].
    Rath EZ; Rumelt S
    Harefuah; 2016 May; 155(5):302-3, 321. PubMed ID: 27526560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Value of Multidetector Computed Tomography of Orbits in Globe Protrusion in Comparison to Hertel Exophthalmometry.
    Đorić I; Žarković M; Radojičić Z; Repac N; Janićijević A; Rotim K; Tasić G; Rasulić L
    Acta Clin Croat; 2017 Mar; 56(1):21-27. PubMed ID: 29120123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessment of soluble E selectin levels in patients with Graves' disease and thyroid orbitopathy].
    Kulig G; Pilarska K; Kulig J; Robaczyk M; Gromniak E
    Przegl Lek; 2004; 61(12):1314-8. PubMed ID: 15850320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rationale for distinguishing the lipogenic form of thyroid orbitopathy].
    Brovkina AF; Iatsenko OIu
    Vestn Oftalmol; 2013; 129(2):30-4. PubMed ID: 23808177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.